Werth, Victoria, Marilyn Pike, Joan Merrill, Eric Morand, Ronald van Vollenhoven, Coburn Hobar, Nikolay Delev, Vaishali Shah, Brian Sharkey, Thomas Wegman, Ian Catlett, Subhashis Banerjee, and Shalabh Singhal. 2023. “Efficacy and Safety of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Patients With Active Systemic Lupus Erythematosus: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study”. SKIN The Journal of Cutaneous Medicine 7 (2):s114. https://doi.org/10.25251/skin.7.supp.114.